A CRITICAL-REVIEW OF THE SAFETY AND ANTIEMETIC EFFICACY OF DELTA-9-TETRAHYDROCANNABINOL

被引：15
作者：
COCCHETTO, DM [1 ]
COOK, LF [1 ]
CATO, AE [1 ]
机构：
[1] BURROUGHS WELLCOME CO,DIV MED,DEPT CLIN RES,RES TRIANGLE PK,NC 27709
来源：
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1981年 / 15卷 / 11期
关键词：
D O I：
10.1177/106002808101501104
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：867 / 875
页数：9
相关论文
共 60 条
[1]  
ANDRYSIAK T, 1979, AM J NURS, V79, P1396
[2]  
BORISON HL, 1979, PHARMACOLOGIST, V21, P205
[3]  
BRAUDE MC, PHARMACOLOGY MARIHUA, V2
[4]  
BRAUDE MC, 1976, PHARMACOLOGY MARIHUA, V1
[5]  
BRECHER EM, 1972, LICIT ILLICIT DRUGS, P403
[6]   DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J].
CHANG, AE ;
SHILING, DJ ;
STILLMAN, RC ;
GOLDBERG, NH ;
SEIPP, CA ;
BAROFSKY, I ;
SIMON, RM ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :819-824
[7]   SIDE EFFECTS OF ANTI-EMETICS - RESULTS OF A CLASS EXPERIMENT [J].
CLARKE, RSJ ;
DUNDEE, JW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1971, 14 (03) :291-&
[8]  
COLLS BM, 1980, NEW ZEAL MED J, V91, P449
[9]  
COLLS BM, 1980, LANCET, V1, P1187
[10]  
EDELSTYN GA, 1979, CLIN ONCOL, V5, P43
123456